TAKEDA PHARMACEUTICAL CO LTD files 6-K

Takeda will withdraw its current shelf registration statement and file a new one in Japan to allow for the issuance of new shares or disposition of treasury shares, up to JPY 240 billion, to support its Long Term Incentive Plan. This action is not intended to raise funds.